Germany's foreign intelligence service in 2020 put at 80%-90% the likelihood that the coronavirus behind the COVID-19 ...

Pfizer paid a whopping $1 billion upfront for rights to vepdegestrant (formerly ARV-4710 in 2021 – consisting of $650 million ...

In 2007 and 2008, Holmes conducted a study for Pfizer investigating the angiogenesis ... companies reagent that is used by LabCorp and many labs across the nation called, R&D Systems VEGF ELISA.

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...

AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Beqvez brings an inauspicious ending to a gene therapy that got its start more than a decade ago in the labs of Spark Therapeutics in Philadelphia. Pfizer's disclosure Friday that it is ending ...

Pfizer Inc.’s next-generation treatment for breast cancer posted mixed results in a final-stage study, a potential setback ...

Pfizer gained as much as 2.6 percent. The lab finding does raise the possibility that this new bat virus could spread from animals to humans, researchers said in a paper published Tuesday in the ...